KPX Lifescience.Co.Ltd (114450) — Capital Reinvestment Ratio
KPX Lifescience.Co.Ltd (114450) has a Capital Reinvestment Ratio of 0.08x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩3.33 Billion) in capital expenditures (₩275.98 Million). Check 114450 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
KPX Lifescience.Co.Ltd Capital Reinvestment Ratio (2014–2024)
This chart tracks KPX Lifescience.Co.Ltd's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of KPX Lifescience.Co.Ltd.
Annual Capital Reinvestment Ratio for KPX Lifescience.Co.Ltd (2014–2024)
Year-by-year Capital Reinvestment Ratio for KPX Lifescience.Co.Ltd from 2014 to 2024. See 114450 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.88x | ₩525.49 Million | ₩462.71 Million | ▼ -31.4% |
| 2023 | 1.28x | ₩370.02 Million | ₩475.02 Million | ▼ -77.2% |
| 2021 | 5.63x | ₩611.38 Million | ₩3.44 Billion | ▲ +301.7% |
| 2020 | 1.40x | ₩1.90 Billion | ₩2.67 Billion | ▲ +65.2% |
| 2019 | 0.85x | ₩4.24 Billion | ₩3.60 Billion | ▼ -39.0% |
| 2018 | 1.39x | ₩5.38 Billion | ₩7.49 Billion | ▲ +83.6% |
| 2017 | 0.76x | ₩5.68 Billion | ₩4.31 Billion | ▲ +234.5% |
| 2016 | 0.23x | ₩7.07 Billion | ₩1.60 Billion | ▲ +141.7% |
| 2015 | 0.09x | ₩5.62 Billion | ₩526.82 Million | ▼ -54.3% |
| 2014 | 0.21x | ₩4.09 Billion | ₩838.78 Million | — |